135 related articles for article (PubMed ID: 28475823)
1. Down-regulated miRs specifically correlate with non-cardial gastric cancers and Lauren's classification system.
Lorenzon L; Cippitelli C; Avantifiori R; Uccini S; French D; Torrisi MR; Ranieri D; Mercantini P; Canu V; Blandino G; Cavallini M
J Surg Oncol; 2017 Aug; 116(2):184-194. PubMed ID: 28475823
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Variation of Lauren Classification in Gastric Cancer.
Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH
Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic features of gastric adenocarcinoma based on the revised Lauren's classification].
Li Y; Xue XW; Luo YF; Wu HW; Chen J; Zhou WX
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):486-491. PubMed ID: 29996311
[No Abstract] [Full Text] [Related]
4. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological Features and Prognosis of Mixed-Type T1a Gastric Cancer Based on Lauren's Classification.
Pyo JH; Ahn S; Lee H; Min BH; Lee JH; Shim SG; Choi MG; Lee JH; Sohn TS; Bae JM; Kim KM; Yeon S; Jung SH; Kim JJ; Kim S
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):784-791. PubMed ID: 27613552
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
Lee OJ; Kim HJ; Kim JR; Watanabe H
Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
[TBL] [Abstract][Full Text] [Related]
7. Vimentin expression is associated with decreased survival in gastric cancer.
Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
[TBL] [Abstract][Full Text] [Related]
8. Significance of Laurén's classification in chemotherapy of gastric carcinoma.
Kakizaki G; Fujiwara Y; Kato E; Saito T; Maeta T; Ishidate T; Ono I
Tohoku J Exp Med; 1976 May; 119(1):41-9. PubMed ID: 951702
[TBL] [Abstract][Full Text] [Related]
9. [Is the Lauren classification an independent parameter for the prognostic evaluation of surgically treated gastric cancer patients? Analysis of a case series].
Midiri G; Eleuteri E; Coppola M; Giarnieri E; Marino G; Di Giovan Paolo M; De Francesco GP; Luzzatto L; Maceratini R; Angelini L
G Chir; 2003; 24(11-12):403-5. PubMed ID: 15018407
[TBL] [Abstract][Full Text] [Related]
10. A prospective correlation of Laurén's histological classification of stomach cancer with clinicopathological findings including DNA flow cytometry.
Lee KH; Lee JH; Cho JK; Kim TW; Kang YK; Lee JS; Kim WK; Chung JG; Lee IC; Sun HS
Pathol Res Pract; 2001; 197(4):223-9. PubMed ID: 11358006
[TBL] [Abstract][Full Text] [Related]
11. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
12. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Lauren's, Ming's and WHO histological classifications of gastric cancer as a prognostic factor for operated patients.
Cimerman M; Repse S; Jelenc F; Omejc M; Bitenc M; Lamovec J
Int Surg; 1994; 79(1):27-32. PubMed ID: 8063551
[TBL] [Abstract][Full Text] [Related]
14. Gastric cancer in a high-risk area in Italy. Histopathologic patterns according to Lauren's classification.
Amorosi A; Bianchi S; Buiatti E; Cipriani F; Palli D; Zampi G
Cancer; 1988 Nov; 62(10):2191-6. PubMed ID: 3179931
[TBL] [Abstract][Full Text] [Related]
15. Tenascin expression in gastric cancer with special emphasis on the WHO-, Lauren-, and Goseki-classifications.
Zirbes TK; Baldus SE; Moenig SP; Schmitz K; Thiele J; Holscher AH; Dienes HP
Int J Mol Med; 1999 Jul; 4(1):39-42. PubMed ID: 10373635
[TBL] [Abstract][Full Text] [Related]
16. Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients.
Woo Y; Behrendt CE; Yang A; Hahn M; Goel A; Li H; Yuan YC; Fong Y
J Am Coll Surg; 2021 Apr; 232(4):483-491.e1. PubMed ID: 33465468
[TBL] [Abstract][Full Text] [Related]
17. [The significance of Laurén's classification of gastric carcinoma].
Tichá V; Jansa P
Cesk Patol; 1986 Mar; 22(1):20-4. PubMed ID: 3955717
[TBL] [Abstract][Full Text] [Related]
18. Differential prognostic implications of gastric adenocarcinoma based on Lauren's classification: a Surveillance, Epidemiology, and End Results (SEER)-based cohort study.
Tang D; Ni M; Zhu H; Cao J; Zhou L; Shen S; Peng C; Lv Y; Xu G; Wang L; Zou X
Ann Transl Med; 2021 Apr; 9(8):646. PubMed ID: 33987344
[TBL] [Abstract][Full Text] [Related]
19. Study of gastric carcinomas with special reference to intestinal metaplasia.
Sethi S; Annamma MO; Preetha K
Indian J Pathol Microbiol; 1999 Jan; 42(1):73-9. PubMed ID: 10420688
[TBL] [Abstract][Full Text] [Related]
20. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.
Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ
Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
